Viatris Analyst Ratings
BenzingaMar 29 00:21
Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $11
BenzingaNov 23, 2023 01:57
Viatris Analyst Ratings
BenzingaNov 23, 2023 01:52
Viatris Downgraded at BofA Citing Business Transition
Seeking AlphaOct 24, 2023 01:41
B of A Securities Downgrades Viatris to Underperform, Announces $9 Price Target
BenzingaOct 23, 2023 19:21
Viatris Analyst Ratings
BenzingaOct 23, 2023 19:20
Piper Sandler Sticks to Their Hold Rating for Viatris (VTRS)
TipRanksAug 8, 2023 20:55
Barclays Downgrades Viatris to Underweight, Announces $11 Price Target
BenzingaJun 23, 2023 17:47
Barclays Downgrades Viatris to Equal-Weight, Lowers Price Target to $11
BenzingaApr 25, 2023 21:06
Barclays Downgrades Viatris to Equal-Weight, Announces $11 Price Target
BenzingaApr 24, 2023 19:00
Barclays Maintains Overweight on Viatris, Raises Price Target to $16
BenzingaFeb 28, 2023 22:35
Barclays Adjusts Price Target on Viatris to $16 From $15, Keeps Overweight Rating
MT NewswiresFeb 28, 2023 20:28
BMO Capital Downgrades Viatris to Market Perform, Lowers Price Target to $14
Benzinga Real-time NewsFeb 17, 2023 18:12
Barclays Adjusts Price Target on Viatris to $15 From $16, Maintains Overweight Rating
MT NewswiresFeb 2, 2023 00:17
Jefferies Upgrades Viatris to Buy, Raises Price Target to $15
Benzinga Real-time NewsJan 27, 2023 19:30
UBS Upgrades Viatris to Neutral From Sell, Adjusts Price Target to $12 From $9
MT NewswiresNov 11, 2022 01:12
Analyst Ratings for Viatris
Benzinga Real-time NewsNov 11, 2022 00:56
UBS Upgrades Viatris to Neutral, Raises Price Target to $12
Benzinga Real-time NewsNov 10, 2022 17:55
Piper Sandler Upgrades Viatris to Neutral, Announces $10 Price Target
Benzinga Real-time NewsNov 8, 2022 17:51
Barclays Adjusts Viatris' Price Target to $16 From $21, Reiterates Overweight Rating
MT NewswiresOct 25, 2022 19:12
No Data
No Data